BRUVIN
The computed 12-month bankruptcy probability of BRUVIN is 0.2% (very low). The 2024 annual accounts show equity of €777k and a net result of €190k. Equity is growing by ~34.7% per year across the filed fiscal years. Its solvency ranks better than 59% of 6553 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €777k |
| Net result | €190k |
| Better than sector | 59% |
| Active | 5 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 73.9% | 66.7% | |
| Net result | €190k | €46k | |
| Equity | €777k | €79k | |
| Gross operating margin | €324k | €78k | |
| Total assets | €1.05M | €154k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €324k |
| Net profit | €190k |
| Cash flow | €241k |
| Staff costs | - |
| Income taxes | €83k |
| Dividends | - |
| Total assets | €1.05M |
| Equity | €777k |
| Debt | €274k |
| of which ≤ 1y | €274k |
| of which > 1y | - |
| Working capital | €-156k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.43 |
| Quick ratio | 0.43 |
| Working capital ratio | -14.9% |
| Solvency | 73.9% |
| Debt / equity | 0.35 |
| Long-term debt ratio | - |
| Interest coverage | 948.51 |
| Gross margin | - |
| Net margin | - |
| ROA | 18.1% |
| ROE | 24.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €1.05M |
| Fixed assets | 21/28 | €933k |
| Tangible fixed assets | 22/27 | €933k |
| Current assets | 29/58 | €118k |
| Amounts receivable within one year | 40/41 | €37k |
| Cash & bank | 54/58 | €73k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.05M |
| Equity | 10/15 | €777k |
| Contributions / capital | 10/11 | €2k |
| Reserves | 13 | €775k |
| Amounts payable | 17/49 | €274k |
| Amounts payable within one year | 42/48 | €274k |
| Trade debts payable within one year | 44 | €170k |
| Income statement | ||
| Gross operating margin | 9900 | €324k |
| Operating result | 9901 | €273k |
| Financial income | 75 | €412 |
| Financial charges | 65 | €342 |
| Result before taxes | 9903 | €273k |
| Income taxes | 67/77 | €83k |
| Net result for the period | 9904 | €190k |
| Result to be appropriated | 9905 | €190k |
| NACE primary | Human health(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 26-10-2020 |
| Status | Active |
| Postal code | 2801 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12012B0040/00G000 | Flanders | 623 m² | 1 · 303 m² | 13.9 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
28-09-2023 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Sabine Van Buggenhout",
"firm_city": null,
"firm_name": null,
"office_city": "Meise",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-09-28",
"filing_date": "2023-09-26",
"act_kind_objet": "DOEL, BENAMING, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"date": "2023-09-13",
"unanimous": true
},
"agm_change": {
"new_schedule": null,
"old_schedule": null,
"effective_from_year": null,
"rule_changes_summary": "Vervanging van artikel 1 (Rechtsvorm - Naam) en artikel 3 (Voorwerp) van de statuten."
},
"detected_kind": "agm_rules_change",
"other_address": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "0757.463.102",
"name_full": "DR. BEN DE BRUCKER, PLASTISCHE CHIRURGIE",
"legal_form": "BV"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"geco\u00F6rdineerde statuten",
"bijzonder verslag van de bestuurders betreffende het voorstel tot wijziging van het voorwerp van de vennootschap"
],
"fiscal_year_change": null,
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BRUVIN |